| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.1 |